In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

All that Jazz: biggest biotech venture round ever

Executive Summary

Jazz Pharmaceuticals, started up last year by a group of former Alza people, raised an astonishing $250mm in its Series B financing. The company's strategy is to in-license a portfolio of known compounds in the neurology and psychiatry fields that it can improve or develop for new uses.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies